These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 22105546)

  • 1. Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management.
    Gyger G; Baron M
    Curr Rheumatol Rep; 2012 Feb; 14(1):22-9. PubMed ID: 22105546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gastrointestinal involvement in systemic sclerosis].
    Marie I
    Presse Med; 2006 Dec; 35(12 Pt 2):1952-65. PubMed ID: 17159722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic sclerosis and the gut.
    Butt S; Emmanuel A
    Expert Rev Gastroenterol Hepatol; 2013 May; 7(4):331-9. PubMed ID: 23639091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation and management of gastrointestinal manifestations in scleroderma.
    Kirby DF; Chatterjee S
    Curr Opin Rheumatol; 2014 Nov; 26(6):621-9. PubMed ID: 25207461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem.
    Ntoumazios SK; Voulgari PV; Potsis K; Koutis E; Tsifetaki N; Assimakopoulos DA
    Semin Arthritis Rheum; 2006 Dec; 36(3):173-81. PubMed ID: 17045629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal involvement in systemic sclerosis: pathogenesis, assessment and treatment.
    Volkmann ER; McMahan Z
    Curr Opin Rheumatol; 2022 Nov; 34(6):328-336. PubMed ID: 35993874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal Manifestations, Malnutrition, and Role of Enteral and Parenteral Nutrition in Patients With Scleroderma.
    Bharadwaj S; Tandon P; Gohel T; Corrigan ML; Coughlin KL; Shatnawei A; Chatterjee S; Kirby DF
    J Clin Gastroenterol; 2015 Aug; 49(7):559-64. PubMed ID: 25992813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal Tract Considerations Part I: How Should a Rheumatologist Best Manage Common Upper Gastrointestinal Tract Complaints in Systemic Sclerosis?
    Quinlivan A; McMahan ZH; Lee EB; Nikpour M
    Rheum Dis Clin North Am; 2023 May; 49(2):295-318. PubMed ID: 37028836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysbiosis and Gut Microbiota Modulation in Systemic Sclerosis.
    Lemos MPC; Zucoloto TG; Oliveira MC; de Oliveira GLV
    J Clin Rheumatol; 2022 Mar; 28(2):e568-e573. PubMed ID: 34030162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing gastrointestinal manifestations in systemic sclerosis, a mechanistic approach.
    Kaniecki T; Hughes M; McMahan Z
    Expert Rev Clin Immunol; 2024 Jun; 20(6):603-622. PubMed ID: 38406978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gastrointestinal features in systemic sclerosis].
    Stelle M; Chizzolini C
    Rev Med Suisse; 2014 Apr; 10(426):860-3. PubMed ID: 24834644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gastrointestinal tract involvement in systemic sclerosis].
    Renaud A; Jirka A; Durant C; Connault J; Espitia O; Takoudju C; Agard C
    Rev Med Interne; 2023 Aug; 44(8):410-422. PubMed ID: 37270380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal manifestations in Hungarian scleroderma patients.
    Szamosi S; Szekanecz Z; Szucs G
    Rheumatol Int; 2006 Oct; 26(12):1120-4. PubMed ID: 16770615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring response in the gastrointestinal tract in systemic sclerosis.
    Khanna D; Nagaraja V; Gladue H; Chey W; Pimentel M; Frech T
    Curr Opin Rheumatol; 2013 Nov; 25(6):700-6. PubMed ID: 24047604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature.
    Jaovisidha K; Csuka ME; Almagro UA; Soergel KH
    Semin Arthritis Rheum; 2005 Feb; 34(4):689-702. PubMed ID: 15692963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal involvement in systemic sclerosis: An updated review.
    Nassar M; Ghernautan V; Nso N; Nyabera A; Castillo FC; Tu W; Medina L; Ciobanu C; Alfishawy M; Rizzo V; Eskaros S; Mahdi M; Khalifa M; El-Kassas M
    Medicine (Baltimore); 2022 Nov; 101(45):e31780. PubMed ID: 36397401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal involvement in systemic sclerosis: an update.
    McMahan ZH
    Curr Opin Rheumatol; 2019 Nov; 31(6):561-568. PubMed ID: 31389815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal manifestations on impaired quality of life in systemic sclerosis.
    Yang H; Xu D; Li MT; Yao Y; Jin M; Zeng XF; Qian JM
    J Dig Dis; 2019 May; 20(5):256-261. PubMed ID: 30838807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence.
    Christmann RB; Wells AU; Capelozzi VL; Silver RM
    Semin Arthritis Rheum; 2010 Dec; 40(3):241-9. PubMed ID: 20494406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal manifestations of scleroderma.
    Young MA; Rose S; Reynolds JC
    Rheum Dis Clin North Am; 1996 Nov; 22(4):797-823. PubMed ID: 8923597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.